Valneva SE Logo

Valneva SE

Specialty vaccine company developing and commercializing vaccines for infectious diseases.

VLA | PA

Overview

Corporate Details

ISIN(s):
AT0000A10B99 (+3 more)
LEI:
969500DIVIP5VKNW4948
Country:
France
Address:
6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN

Description

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2014-07-02 18:50
Valneva Bilan semestriel du contrat de liquidité Juin 2014
French 59.3 KB
2014-06-05 22:42
2014_06_05 Availability of preparatory documents FR
English 19.7 KB
2014-06-05 22:41
2014_06_05 Availability of preparatory documents FR
English 19.7 KB
2014-06-02 18:50
2014_06_02Déclaration droits de vote
French 8.6 KB
2014-05-19 08:31
2014_05_19 Valneva MDPV PR FR
French 267.1 KB
2014-05-13 08:30
2014_05_13 Valneva Q1 PR FR
French 561.0 KB
2014-05-02 18:59
2014-05-02 Declaration Droits de Vote Valneva
French 8.6 KB
2014-04-30 17:34
2014-04-30 Valneva filing PR FR
French 178.7 KB
2014-04-15 08:30
2014_04_15 Valneva PEA-PME PR
French 207.9 KB
2014-04-10 10:00
2014-04-10 Valneva Adimmune PR FR
French 268.8 KB
2014-04-07 23:00
Déckaration actions et droits de vote mars 2014
French 8.7 KB
2014-03-24 17:40
2014_03_24 Valneva Human Vaccine PR
French 214.8 KB
2014-03-24 07:30
2014_03_24 Valneva FY Results PR FR
French 269.7 KB
2014-03-24 07:00
2014-03-24 Valneva Pseudo Continuation PR FR
French 507.1 KB
2014-03-13 07:30
2014-03-13 Valneva Farvet PR FR
French 269.3 KB

Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Valneva SE

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Valneva SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-03-18 N/A Other Buy 44,222 N/A
2024-01-03 N/A Other Other 34,802 N/A
2023-06-20 N/A Other Sell 192,547 1,406,228.50 EUR
2023-06-19 N/A Other Sell 30,661 209,629.26 EUR
2023-06-16 N/A Other Sell 85,589 582,493.06 EUR
2023-06-15 N/A Other Sell 28,179 189,503.78 EUR
2023-06-14 N/A Other Sell 228,951 1,519,914.11 EUR
2023-06-13 N/A Other Sell 29,401 187,922.37 EUR
2023-06-12 N/A Other Sell 117,854 733,782.57 EUR
2023-05-10 N/A Other Buy 87,523 N/A

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.